Sanofi Financial Statements From 2010 to 2024

SNY Stock  USD 49.29  0.28  0.57%   
Sanofi ADR financial statements provide useful quarterly and yearly information to potential Sanofi ADR investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sanofi ADR financial statements helps investors assess Sanofi ADR's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sanofi ADR's valuation are summarized below:
Gross Profit
31.7 B
Profit Margin
0.098
Market Capitalization
122.9 B
Enterprise Value Revenue
2.7108
Revenue
46.3 B
We have found one hundred twenty available fundamental trend indicators for Sanofi ADR, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Sanofi ADR current market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 67.8 B in 2024. Enterprise Value is likely to drop to about 73.8 B in 2024

Sanofi ADR Total Revenue

31.04 Billion

Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi main balance sheet or income statement drivers, such as Depreciation And Amortization of 4 B, Interest Expense of 1.1 B or Selling General Administrative of 11.2 B, as well as many exotic indicators such as Price To Sales Ratio of 3.95, Dividend Yield of 0.0228 or PTB Ratio of 1.44. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
  
This module can also supplement Sanofi ADR's financial leverage analysis and stock options assessment as well as various Sanofi ADR Technical models . Check out the analysis of Sanofi ADR Correlation against competitors.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Sanofi ADR Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets88.2 B126.5 B100.4 B
Slightly volatile
Short and Long Term Debt Total13.7 B18.4 B17.4 B
Slightly volatile
Other Current Liabilities14.6 B13.9 B2.3 B
Slightly volatile
Total Current Liabilities14.3 B24.2 B16.6 B
Slightly volatile
Total Stockholder Equity50.2 B74 B56.7 B
Slightly volatile
Property Plant And Equipment Net8.5 B11.8 B9.9 B
Slightly volatile
Net Debt7.6 B9.7 B9.1 B
Slightly volatile
Accounts Payable9.1 B7.3 B12.1 B
Slightly volatile
Cash6.1 B8.7 B8.3 B
Slightly volatile
Non Current Assets Total66.2 B95.8 B74.3 B
Slightly volatile
Cash And Short Term Investments6.9 B8.7 B8.5 B
Slightly volatile
Net Receivables6.4 B11 B6.8 B
Pretty Stable
Good Will33.9 B49.4 B39.1 B
Slightly volatile
Common Stock Total Equity2.6 B2.9 B2.5 B
Slightly volatile
Common Stock Shares Outstanding1.3 B1.3 B1.3 B
Pretty Stable
Short Term Investments256.5 M270 M422.8 M
Very volatile
Liabilities And Stockholders Equity88.2 B126.5 B100.4 B
Slightly volatile
Non Current Liabilities Total23.5 B27.9 B26.9 B
Slightly volatile
Inventory11.4 B9.7 B15.4 B
Pretty Stable
Total Liabilities37.8 B52.1 B43.5 B
Slightly volatile
Property Plant And Equipment Gross28.8 B27.4 B12.2 B
Slightly volatile
Total Current Assets22 B30.7 B26.1 B
Slightly volatile
Short Term Debt2.9 B2.3 B2.9 B
Slightly volatile
Intangible Assets77.3 B73.6 B26.6 B
Slightly volatile
Common Stock2.6 B2.5 B2.5 B
Slightly volatile
Other Liabilities11.9 B12.5 B12.9 B
Very volatile
Current Deferred Revenue567.1 M597 M2.6 B
Slightly volatile
Other Assets9.8 B14.8 B9.2 B
Slightly volatile
Long Term Debt12.7 B14.3 B15.9 B
Pretty Stable
Property Plant Equipment10.5 B13.4 B11.6 B
Very volatile
Deferred Long Term LiabilitiesB7.2 B3.6 B
Slightly volatile
Long Term Investments2.5 B2.7 B5.4 B
Pretty Stable
Short and Long Term Debt3.2 BBB
Slightly volatile
Net Invested Capital94 B90.4 B80.5 B
Slightly volatile
Net Working Capital7.7 B6.5 B10.1 B
Slightly volatile
Capital Stock2.8 B2.5 B2.5 B
Slightly volatile

Sanofi ADR Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative11.2 B10.7 BB
Slightly volatile
Total Revenue31 B43.1 B34.3 B
Slightly volatile
Gross Profit21.8 B26.5 B23.4 B
Slightly volatile
Other Operating Expenses35.6 B33.9 B16.5 B
Slightly volatile
Operating Income8.7 B9.2 B10.4 B
Pretty Stable
EBIT8.7 B9.2 B10.4 B
Pretty Stable
Research Development4.9 B6.7 B5.2 B
Slightly volatile
EBITDA9.8 B13 B10.1 B
Slightly volatile
Cost Of Revenue9.3 B16.6 B11 B
Slightly volatile
Total Operating Expenses15 B17.3 B16.2 B
Slightly volatile
Income Before Tax5.6 B7.2 B6.1 B
Slightly volatile
Net Income4.6 B5.4 B5.1 B
Slightly volatile
Income Tax Expense1.2 B1.6 B1.1 B
Slightly volatile
Net Income Applicable To Common Shares5.9 B9.6 B6.2 B
Slightly volatile
Selling And Marketing Expenses9.7 B10.8 B9.3 B
Slightly volatile
Net Income From Continuing Ops6.3 B5.4 B5.4 B
Slightly volatile
Tax Provision1.3 B1.6 BB
Slightly volatile
Interest Income573.3 M546 M220.4 M
Slightly volatile
Reconciled Depreciation3.1 B4.8 B3.8 B
Very volatile

Sanofi ADR Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow5.6 BB5.9 B
Slightly volatile
Begin Period Cash Flow6.4 B12.7 B8.2 B
Slightly volatile
Depreciation4.1 B3.8 B4.1 B
Very volatile
Dividends Paid2.9 B4.5 B3.4 B
Slightly volatile
Capital Expenditures1.7 B3.3 B1.9 B
Slightly volatile
Total Cash From Operating Activities7.3 B10.3 B7.8 B
Slightly volatile
Net Income4.6 B5.4 B5.4 B
Slightly volatile
End Period Cash Flow6.7 B8.7 B8.4 B
Slightly volatile
Change To Liabilities339.2 M519.8 M332.6 M
Slightly volatile
Issuance Of Capital Stock203.7 M195 M182 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.952.60863.0139
Pretty Stable
Dividend Yield0.02280.03960.0327
Slightly volatile
PTB Ratio1.441.51752.072
Slightly volatile
Days Sales Outstanding86.4493.559375.4319
Slightly volatile
Book Value Per Share62.1159.151645.9968
Slightly volatile
Free Cash Flow Yield0.04820.06230.0587
Very volatile
Invested Capital0.180.22510.2873
Pretty Stable
Operating Cash Flow Per Share4.338.19536.002
Slightly volatile
Stock Based Compensation To Revenue0.00510.00660.006
Slightly volatile
PB Ratio1.441.51752.072
Slightly volatile
EV To Sales4.22.83413.2676
Pretty Stable
Free Cash Flow Per Share3.35.59644.5104
Slightly volatile
ROIC0.140.07860.1246
Slightly volatile
Inventory Turnover1.341.71450.8586
Very volatile
Net Income Per Share2.694.31413.9462
Slightly volatile
Days Of Inventory On Hand310213493
Very volatile
Payables Turnover1.632.26151.1008
Very volatile
Research And Ddevelopement To Revenue0.190.15610.1534
Slightly volatile
Cash Per Share4.347.17426.8587
Slightly volatile
POCF Ratio17.3610.952714.2676
Slightly volatile
Payout Ratio0.450.82480.7418
Very volatile
PFCF Ratio29.4916.038921.1536
Pretty Stable
Days Payables Outstanding250161386
Pretty Stable
Income Quality1.181.89961.5687
Pretty Stable
ROE0.130.07290.0968
Very volatile
EV To Operating Cash Flow18.4511.899515.445
Pretty Stable
PE Ratio24.4920.80623.0097
Slightly volatile
Return On Tangible Assets0.140.10210.1138
Pretty Stable
EV To Free Cash Flow30.9317.425422.7685
Pretty Stable
Earnings Yield0.03870.04810.0515
Pretty Stable
Intangibles To Total Assets0.380.58180.5094
Pretty Stable
Net Debt To EBITDA0.690.74940.8761
Pretty Stable
Current Ratio1.881.2671.6534
Slightly volatile
Receivables Turnover3.713.901317.5648
Slightly volatile
Graham Number42.3875.774261.4312
Slightly volatile
Shareholders Equity Per Share62.1159.151645.9968
Slightly volatile
Debt To Equity0.180.22510.2873
Pretty Stable
Revenue Per Share18.2934.409226.641
Slightly volatile
Interest Debt Per Share8.1714.189513.3898
Slightly volatile
Debt To Assets0.10.13180.1608
Pretty Stable
Enterprise Value Over EBITDA13.899.419311.5601
Pretty Stable
Short Term Coverage Ratios3.764.42162.9833
Pretty Stable
Price Earnings Ratio24.4920.80623.0097
Slightly volatile
Operating Cycle373306567
Pretty Stable
Price Book Value Ratio1.441.51752.072
Slightly volatile
Days Of Payables Outstanding250161386
Pretty Stable
Dividend Payout Ratio0.450.82480.7418
Very volatile
Price To Operating Cash Flows Ratio17.3610.952714.2676
Slightly volatile
Price To Free Cash Flows Ratio29.4916.038921.1536
Pretty Stable
Pretax Profit Margin0.210.16610.1843
Pretty Stable
Ebt Per Ebit1.110.77890.6929
Slightly volatile
Operating Profit Margin0.220.21320.2949
Pretty Stable
Effective Tax Rate0.20.2240.1865
Pretty Stable
Company Equity Multiplier1.41.7081.7564
Slightly volatile
Long Term Debt To Capitalization0.110.16230.1859
Slightly volatile
Total Debt To Capitalization0.140.18370.2194
Pretty Stable
Return On Capital Employed0.170.08980.1341
Slightly volatile
Debt Equity Ratio0.180.22510.2873
Pretty Stable
Ebit Per Revenue0.220.21320.2949
Pretty Stable
Quick Ratio1.220.82751.0255
Slightly volatile
Net Income Per E B T0.670.75490.8147
Pretty Stable
Cash Ratio0.290.360.4674
Pretty Stable
Cash Conversion Cycle123145181
Slightly volatile
Operating Cash Flow Sales Ratio0.260.23820.2237
Pretty Stable
Days Of Inventory Outstanding310213493
Very volatile
Days Of Sales Outstanding86.4493.559375.4319
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.580.68290.7234
Very volatile
Cash Flow Coverage Ratios0.580.61550.5594
Slightly volatile
Price To Book Ratio1.441.51752.072
Slightly volatile
Fixed Asset Turnover4.373.64573.6043
Pretty Stable
Price Cash Flow Ratio17.3610.952714.2676
Slightly volatile
Enterprise Value Multiple13.899.419311.5601
Pretty Stable
Debt Ratio0.10.13180.1608
Pretty Stable
Cash Flow To Debt Ratio0.580.61550.5594
Slightly volatile
Price Sales Ratio3.952.60863.0139
Pretty Stable
Return On Assets0.07730.04270.0545
Very volatile
Asset Turnover0.470.34060.3776
Slightly volatile
Net Profit Margin0.120.12540.1435
Pretty Stable
Gross Profit Margin0.790.61520.6897
Very volatile
Price Fair Value1.441.51752.072
Slightly volatile
Return On Equity0.130.07290.0968
Very volatile

Sanofi ADR Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap67.8 B101.2 B95.2 B
Pretty Stable
Enterprise Value73.8 B108.9 B103.6 B
Slightly volatile

Sanofi Fundamental Market Drivers

Forward Price Earnings11.1359
Cash And Short Term Investments8.7 B

Sanofi Upcoming Events

1st of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
1st of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Sanofi ADR Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Sanofi ADR income statement, its balance sheet, and the statement of cash flows. Sanofi ADR investors use historical funamental indicators, such as Sanofi ADR's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sanofi ADR investors may use each financial statement separately, they are all related. The changes in Sanofi ADR's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sanofi ADR's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Sanofi ADR Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue597 M567.1 M
Total Revenue43.1 B31 B
Cost Of Revenue16.6 B9.3 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0  0 
Research And Ddevelopement To Revenue 0.16  0.19 
Capex To Revenue(0.08)(0.08)
Revenue Per Share 34.41  18.29 
Ebit Per Revenue 0.21  0.22 

Sanofi ADR Investors Sentiment

The influence of Sanofi ADR's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Sanofi. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Sanofi ADR's public news can be used to forecast risks associated with an investment in Sanofi. The trend in average sentiment can be used to explain how an investor holding Sanofi can time the market purely based on public headlines and social activities around Sanofi ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Sanofi ADR's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Sanofi ADR's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Sanofi ADR's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Sanofi ADR.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sanofi ADR in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sanofi ADR's short interest history, or implied volatility extrapolated from Sanofi ADR options trading.

Currently Active Assets on Macroaxis

When determining whether Sanofi ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanofi ADR's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanofi Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanofi Adr Stock:
Check out the analysis of Sanofi ADR Correlation against competitors.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Sanofi Stock analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.43)
Earnings Share
1.94
Revenue Per Share
18.492
Quarterly Revenue Growth
0.023
Return On Assets
0.0454
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.